“…Apoptotic pathways might be significantly altered in cancer cells with respect to untransformed cells, and these differences may represent a therapeutic window that can be explored for the development of new antineoplastic drugs. There are reports in the literature of the cytoprotector effects of glycine and its nitrogen derivatives, evaluated in different models of damage related to the accumulation of free radicals (Tripathi et al, 2000;Yan-Jun et al, 2000;Ascher et al, 2001;Jacob et al, 2003;Tanonaka et al, 2002). Substantial data supports the existence of a glycine receptor in the membrane of the cell, whose activation reduces the release of reactive oxygen species (ROS), thus protecting the cell from damage by the latter (Yan-Jun et al, 2000;Jacob et al, 2003).…”